[{"id":"c3f91db3-f89a-454a-9211-dc69a8dcc486","acronym":"EOSDOEOSQ","url":"https://clinicaltrials.gov/study/NCT06773143","created_at":"2025-02-25T15:37:59.408Z","updated_at":"2025-02-25T15:37:59.408Z","phase":"","brief_title":"Effect of Subanesthetic Dose of Esketamine on Sleep Quality","source_id_and_acronym":"NCT06773143 - EOSDOEOSQ","lead_sponsor":"Nanjing First Hospital, Nanjing Medical University","biomarkers":" IL6 • TNFA • BDNF","pipe":"","alterations":" ","tags":["IL6 • TNFA • BDNF"],"overall_status":"Recruiting","enrollment":" Enrollment 184","initiation":"Initiation: 12/30/2024","start_date":" 12/30/2024","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 04/30/2027","study_completion_date":" 04/30/2027","last_update_posted":"2025-02-10"},{"id":"e083e3f6-9297-475c-8844-e43c062a3d0a","acronym":"DAANCE","url":"https://clinicaltrials.gov/study/NCT06749210","created_at":"2025-02-26T07:40:40.489Z","updated_at":"2025-02-26T07:40:40.489Z","phase":"Phase 2","brief_title":"DAANCE FOR CHEMOTHERAPY-INDUCED NEUROPATHY","source_id_and_acronym":"NCT06749210 - DAANCE","lead_sponsor":"Ohio State University Comprehensive Cancer Center","biomarkers":" IL6 • TNFA • IL10 • BDNF • GFAP","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL10 • BDNF • GFAP"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 140","initiation":"Initiation: 01/01/2025","start_date":" 01/01/2025","primary_txt":" Primary completion: 09/01/2030","primary_completion_date":" 09/01/2030","study_txt":" Completion: 09/01/2030","study_completion_date":" 09/01/2030","last_update_posted":"2025-01-06"},{"id":"1f03d618-be31-41e9-b5f3-97ec0ce2a2ce","acronym":"","url":"https://clinicaltrials.gov/study/NCT06580002","created_at":"2025-02-26T10:15:43.559Z","updated_at":"2025-02-26T10:15:43.559Z","phase":"Phase 2","brief_title":"Repurposing Riluzole for Cancer-Related Cognitive Impairment: a Pilot Trial","source_id_and_acronym":"NCT06580002","lead_sponsor":"University of California, Irvine","biomarkers":" BDNF","pipe":"","alterations":" ","tags":["BDNF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e riluzole"],"overall_status":"Recruiting","enrollment":" Enrollment 34","initiation":"Initiation: 12/02/2024","start_date":" 12/02/2024","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2024-12-06"},{"id":"818fa4a2-3999-4978-a908-8798a8ccd16f","acronym":"","url":"https://clinicaltrials.gov/study/NCT06664736","created_at":"2025-02-26T15:16:43.450Z","updated_at":"2025-02-26T15:16:43.450Z","phase":"","brief_title":"Effects of Home-Based Exercise Program in Children After Acute Lymphoblastic Leukemia","source_id_and_acronym":"NCT06664736","lead_sponsor":"Gazi University","biomarkers":" IL6 • TNFA • IL1B • BDNF","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL1B • BDNF"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 05/30/2023","start_date":" 05/30/2023","primary_txt":" Primary completion: 05/30/2024","primary_completion_date":" 05/30/2024","study_txt":" Completion: 05/30/2024","study_completion_date":" 05/30/2024","last_update_posted":"2024-10-29"},{"id":"48cd0756-0eba-4579-b423-745ea4ae5df7","acronym":"","url":"https://clinicaltrials.gov/study/NCT06171152","created_at":"2023-12-14T17:18:20.281Z","updated_at":"2024-07-02T16:35:03.759Z","phase":"Phase 1","brief_title":"Study of Liraglutide (A Weight Loss Drug) in High Risk Obese Participants With Cognitive and Memory Issues","source_id_and_acronym":"NCT06171152","lead_sponsor":"University of Chicago","biomarkers":" BDNF","pipe":"","alterations":" ","tags":["BDNF"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 11/01/2024","start_date":" 11/01/2024","primary_txt":" Primary completion: 06/01/2026","primary_completion_date":" 06/01/2026","study_txt":" Completion: 10/01/2026","study_completion_date":" 10/01/2026","last_update_posted":"2024-05-14"},{"id":"6925d108-67a2-4482-85b3-f7c5abaed179","acronym":"IMPULS","url":"https://clinicaltrials.gov/study/NCT06145074","created_at":"2023-11-22T19:17:29.191Z","updated_at":"2024-07-02T16:35:12.435Z","phase":"Phase 2","brief_title":"Examining Safety, Efficacy and Feasibility of Preoperative Propranolol in Patients With PDAC.","source_id_and_acronym":"NCT06145074 - IMPULS","lead_sponsor":"Zealand University Hospital","biomarkers":" ADRB2 • BDNF","pipe":"","alterations":" ","tags":["ADRB2 • BDNF"],"overall_status":"Recruiting","enrollment":" Enrollment 30","initiation":"Initiation: 03/20/2024","start_date":" 03/20/2024","primary_txt":" Primary completion: 12/31/2026","primary_completion_date":" 12/31/2026","study_txt":" Completion: 12/31/2035","study_completion_date":" 12/31/2035","last_update_posted":"2024-03-28"},{"id":"a92b15f5-28ca-4135-b170-54b6cc0b170e","acronym":"ONKO-FRAIL","url":"https://clinicaltrials.gov/study/NCT05131113","created_at":"2021-11-23T13:53:32.006Z","updated_at":"2024-07-02T16:35:33.957Z","phase":"","brief_title":"Stratification of Patients in Oncogeriatrics and Personalization of Interventions","source_id_and_acronym":"NCT05131113 - ONKO-FRAIL","lead_sponsor":"Asociacion Instituto Biodonostia","biomarkers":" IFNG • IL6 • TNFA • IL2 • IL1B • BDNF • CRP • EGR1 • GJB6 • MIR454","pipe":"","alterations":" ","tags":["IFNG • IL6 • TNFA • IL2 • IL1B • BDNF • CRP • EGR1 • GJB6 • MIR454"],"overall_status":"Recruiting","enrollment":" Enrollment 200","initiation":"Initiation: 01/27/2022","start_date":" 01/27/2022","primary_txt":" Primary completion: 01/01/2024","primary_completion_date":" 01/01/2024","study_txt":" Completion: 11/30/2024","study_completion_date":" 11/30/2024","last_update_posted":"2023-10-11"},{"id":"37a9eadc-1c33-405b-8e59-1dbd8a32eab0","acronym":"","url":"https://clinicaltrials.gov/study/NCT04993859","created_at":"2021-08-06T12:52:57.238Z","updated_at":"2024-07-02T16:35:39.271Z","phase":"","brief_title":"Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children","source_id_and_acronym":"NCT04993859","lead_sponsor":"University of Colorado, Denver","biomarkers":" BDNF","pipe":"","alterations":" ","tags":["BDNF"],"overall_status":"Recruiting","enrollment":" Enrollment 152","initiation":"Initiation: 06/02/2021","start_date":" 06/02/2021","primary_txt":" Primary completion: 07/09/2024","primary_completion_date":" 07/09/2024","study_txt":" Completion: 07/09/2025","study_completion_date":" 07/09/2025","last_update_posted":"2023-08-23"},{"id":"c18a797f-f388-457a-8936-39bcb7181e0b","acronym":"MyBrain","url":"https://clinicaltrials.gov/study/NCT05840575","created_at":"2023-05-03T15:04:43.419Z","updated_at":"2024-07-02T16:35:49.160Z","phase":"","brief_title":"Investigating Cognitive Impairment in Young Patients With Cancer Prospectively","source_id_and_acronym":"NCT05840575 - MyBrain","lead_sponsor":"Rigshospitalet, Denmark","biomarkers":" IL6 • TNFA • IL10 • IL17A • BDNF • GFAP • NEFL","pipe":"","alterations":" ","tags":["IL6 • TNFA • IL10 • IL17A • BDNF • GFAP • NEFL"],"overall_status":"Recruiting","enrollment":" Enrollment 100","initiation":"Initiation: 03/01/2022","start_date":" 03/01/2022","primary_txt":" Primary completion: 03/01/2027","primary_completion_date":" 03/01/2027","study_txt":" Completion: 03/01/2027","study_completion_date":" 03/01/2027","last_update_posted":"2023-05-02"},{"id":"e5907a52-05e3-4c76-8f74-b95c8e5888dd","acronym":"EfiKroniK","url":"https://clinicaltrials.gov/study/NCT03810755","created_at":"2021-01-18T18:49:45.490Z","updated_at":"2024-07-02T16:35:56.201Z","phase":"","brief_title":"EfiKroniK Research Program: Physical Exercise for People With Chronic Pathologies","source_id_and_acronym":"NCT03810755 - EfiKroniK","lead_sponsor":"Basque Health Service","biomarkers":" BDNF","pipe":"","alterations":" ","tags":["BDNF"],"overall_status":"Completed","enrollment":" Enrollment 370","initiation":"Initiation: 01/10/2018","start_date":" 01/10/2018","primary_txt":" Primary completion: 07/31/2021","primary_completion_date":" 07/31/2021","study_txt":" Completion: 12/31/2022","study_completion_date":" 12/31/2022","last_update_posted":"2023-02-08"},{"id":"b40f5405-7317-4d5f-95f8-007259e0a620","acronym":"iHBE","url":"https://clinicaltrials.gov/study/NCT03874754","created_at":"2021-01-18T19:06:15.655Z","updated_at":"2024-07-02T16:36:03.726Z","phase":"","brief_title":"Tailored Home-Based Exercise Program for Multiple Chronic Conditions","source_id_and_acronym":"NCT03874754 - iHBE","lead_sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","biomarkers":" BDNF","pipe":"","alterations":" ","tags":["BDNF"],"overall_status":"Completed","enrollment":" Enrollment 34","initiation":"Initiation: 08/01/2019","start_date":" 08/01/2019","primary_txt":" Primary completion: 01/31/2021","primary_completion_date":" 01/31/2021","study_txt":" Completion: 06/30/2021","study_completion_date":" 06/30/2021","last_update_posted":"2022-09-21"},{"id":"f0b0e333-75aa-4854-b7f2-839721cf93b0","acronym":"","url":"https://clinicaltrials.gov/study/NCT05305092","created_at":"2022-03-31T16:52:39.507Z","updated_at":"2024-07-02T16:36:07.335Z","phase":"","brief_title":"Assessment of Brain Cognitive Impairment in Breast Cancer","source_id_and_acronym":"NCT05305092","lead_sponsor":"Tang-Du Hospital","biomarkers":" VEGFA • IL10 • BDNF • GFAP","pipe":"","alterations":" ","tags":["VEGFA • IL10 • BDNF • GFAP"],"overall_status":"Recruiting","enrollment":" Enrollment 90","initiation":"Initiation: 05/31/2022","start_date":" 05/31/2022","primary_txt":" Primary completion: 05/30/2027","primary_completion_date":" 05/30/2027","study_txt":" Completion: 05/30/2027","study_completion_date":" 05/30/2027","last_update_posted":"2022-07-13"},{"id":"0d8e5df6-6d97-4be5-a539-125ca96165e7","acronym":"","url":"https://clinicaltrials.gov/study/NCT03476070","created_at":"2021-01-18T17:07:39.507Z","updated_at":"2024-07-02T16:36:24.842Z","phase":"","brief_title":"Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)","source_id_and_acronym":"NCT03476070","lead_sponsor":"National University, Singapore","biomarkers":" IL6 • IL1B • BDNF","pipe":"","alterations":" ","tags":["IL6 • IL1B • BDNF"],"overall_status":"Recruiting","enrollment":" Enrollment 236","initiation":"Initiation: 06/18/2018","start_date":" 06/18/2018","primary_txt":" Primary completion: 03/01/2022","primary_completion_date":" 03/01/2022","study_txt":" Completion: 09/01/2022","study_completion_date":" 09/01/2022","last_update_posted":"2021-09-05"},{"id":"44b23d2a-b087-4118-a03c-973d0274971d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03753399","created_at":"2021-01-18T18:27:13.189Z","updated_at":"2024-07-02T16:36:29.974Z","phase":"","brief_title":"Effect of Acupuncture for QoL in Gastric Cancer Patients Undergoing Adjuvant Chemotherapy: a Pilot Study","source_id_and_acronym":"NCT03753399","lead_sponsor":"Guangzhou University of Traditional Chinese Medicine","biomarkers":" CD8 • IFNG • IL6 • TNFA • CXCL12 • IL2 • IL10 • CCL4 • FGF • IL18 • IL17A • IL23A • IFNA1 • IL1B • IL21 • IL22 • BDNF","pipe":"","alterations":" ","tags":["CD8 • IFNG • IL6 • TNFA • CXCL12 • IL2 • IL10 • CCL4 • FGF • IL18 • IL17A • IL23A • IFNA1 • IL1B • IL21 • IL22 • BDNF"],"overall_status":"Completed","enrollment":" Enrollment 66","initiation":"Initiation: 01/04/2019","start_date":" 01/04/2019","primary_txt":" Primary completion: 04/27/2020","primary_completion_date":" 04/27/2020","study_txt":" Completion: 04/27/2020","study_completion_date":" 04/27/2020","last_update_posted":"2021-05-20"},{"id":"edf53596-6aa6-468f-8663-c4465c482691","acronym":"","url":"https://clinicaltrials.gov/study/NCT02895178","created_at":"2021-01-18T14:12:21.018Z","updated_at":"2024-07-02T16:36:32.226Z","phase":"","brief_title":"Lifestyles Of Health And Sustainability for Breast Cancer Survivors","source_id_and_acronym":"NCT02895178","lead_sponsor":"Wonju Severance Christian Hospital","biomarkers":" CTNNB1 • TNFA • DKK1 • GDF15 • IL10 • FGF21 • IL1B • SFRP1 • BDNF • TNFRSF11B","pipe":"","alterations":" ","tags":["CTNNB1 • TNFA • DKK1 • GDF15 • IL10 • FGF21 • IL1B • SFRP1 • BDNF • TNFRSF11B"],"overall_status":"Recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 05/01/2014","start_date":" 05/01/2014","primary_txt":" Primary completion: 03/01/2023","primary_completion_date":" 03/01/2023","study_txt":" Completion: 12/01/2023","study_completion_date":" 12/01/2023","last_update_posted":"2021-04-08"},{"id":"c288adad-cfb3-4401-9a6f-a4cddbc11475","acronym":"","url":"https://clinicaltrials.gov/study/NCT03452436","created_at":"2021-01-18T17:01:31.045Z","updated_at":"2024-07-02T16:36:47.685Z","phase":"","brief_title":"Testosterone, Cognition, Ageing, and Cancer","source_id_and_acronym":"NCT03452436","lead_sponsor":"University of Aarhus","biomarkers":" APOE • BDNF • COMT","pipe":"","alterations":" ","tags":["APOE • BDNF • COMT"],"overall_status":"Completed","enrollment":" Enrollment 133","initiation":"Initiation: 02/12/2018","start_date":" 02/12/2018","primary_txt":" Primary completion: 03/01/2020","primary_completion_date":" 03/01/2020","study_txt":" Completion: 03/01/2020","study_completion_date":" 03/01/2020","last_update_posted":"2020-03-25"},{"id":"835b9b85-c888-4ffc-b3c2-70718658fc1d","acronym":"GME","url":"https://clinicaltrials.gov/study/NCT04213872","created_at":"2021-09-05T23:53:35.572Z","updated_at":"2024-07-02T16:36:51.988Z","phase":"","brief_title":"Gene Expression, Meditative Movement, and Emotional Distress (GME)","source_id_and_acronym":"NCT04213872 - GME","lead_sponsor":"Arizona State University","biomarkers":" BDNF","pipe":"","alterations":" ","tags":["BDNF"],"overall_status":"Unknown status","enrollment":" Enrollment 27","initiation":"Initiation: 07/17/2017","start_date":" 07/17/2017","primary_txt":" Primary completion: 11/15/2018","primary_completion_date":" 11/15/2018","study_txt":" Completion: 02/15/2020","study_completion_date":" 02/15/2020","last_update_posted":"2019-12-30"},{"id":"787f9f93-7ecd-46c7-8dde-806b685bbef3","acronym":"","url":"https://clinicaltrials.gov/study/NCT03624751","created_at":"2021-01-18T17:48:27.283Z","updated_at":"2024-07-02T16:37:07.985Z","phase":"","brief_title":"Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment","source_id_and_acronym":"NCT03624751","lead_sponsor":"Taichung Veterans General Hospital","biomarkers":" VCAM1 • BDNF","pipe":"","alterations":" ","tags":["VCAM1 • BDNF"],"overall_status":"Recruiting","enrollment":" Enrollment 300","initiation":"Initiation: 06/30/2018","start_date":" 06/30/2018","primary_txt":" Primary completion: 06/30/2028","primary_completion_date":" 06/30/2028","study_txt":" Completion: 06/30/2030","study_completion_date":" 06/30/2030","last_update_posted":"2018-08-10"},{"id":"1ff1f73d-08e4-486e-a3a7-96b4b9189221","acronym":"PULSAR","url":"https://clinicaltrials.gov/study/NCT01503359","created_at":"2021-01-18T06:18:43.011Z","updated_at":"2024-07-02T16:37:29.078Z","phase":"Phase 2","brief_title":"Effect of Sarcosine on Symptomatology, Quality of Life, Oxidative Stress and Glutamatergic Parameters in Schizophrenia","source_id_and_acronym":"NCT01503359 - PULSAR","lead_sponsor":"Medical University of Lodz","biomarkers":" MMP9 • BDNF","pipe":"","alterations":" ","tags":["MMP9 • BDNF"],"overall_status":"Completed","enrollment":" Enrollment 70","initiation":"Initiation: 01/01/2012","start_date":" 01/01/2012","primary_txt":" Primary completion: 02/01/2015","primary_completion_date":" 02/01/2015","study_txt":" Completion: 01/01/2016","study_completion_date":" 01/01/2016","last_update_posted":"2016-09-16"},{"id":"976662e5-c9f9-45e1-a8a7-ec85c4257402","acronym":"","url":"https://clinicaltrials.gov/study/NCT01387724","created_at":"2021-01-18T05:41:39.859Z","updated_at":"2024-07-02T16:37:31.996Z","phase":"","brief_title":"Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma","source_id_and_acronym":"NCT01387724","lead_sponsor":"Children's Oncology Group","biomarkers":" NTRK2 • MYCN • BDNF","pipe":" | ","alterations":" MYCN amplification • MYCN expression • NTRK expression","tags":["NTRK2 • MYCN • BDNF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MYCN amplification • MYCN expression • NTRK expression"],"overall_status":"Completed","enrollment":" Enrollment 300","initiation":"Initiation: 06/01/2011","start_date":" 06/01/2011","primary_txt":" Primary completion: 05/01/2016","primary_completion_date":" 05/01/2016","study_txt":"","study_completion_date":"","last_update_posted":"2016-05-18"}]